Sign Up Today and Learn More About BioVersys Stock
Invest in or calculate the value of your shares in BioVersys or other pre-IPO companies through EquityZen's platform.
BioVersys Stock (BIOV)
BioVersys is a privately held Swiss biopharmaceutical company.
About BioVersys Stock
Founded
2008
Industries
Software, Artificial Intelligence, Financial Services
BioVersys Press Mentions
Stay in the know about the latest news on BioVersys
Other news to note for Feb. 12, 2025
bioworld • Feb 13, 2025
Bioversys identifies optimized lead compounds in BV500 NTM program
bioworld • Feb 13, 2025
BIOVERSYS SUCCESSFULLY ADVANCES BV500 NTM PROGRAM WITH CO...
pharmiweb • Feb 11, 2025
BioVersys Successfully Advances Bv500 NTM Program with Continued Support from CF AMR Syndicate
morningstar • Feb 11, 2025
BioVersys begins trading on SIX Swiss Exchange
venturelab • Feb 07, 2025
BioVersys Management
Leadership team at BioVersys
CSO
Sergio Lociuro
Chairman of the Board
Seng Chin Mah
Join now and verify your accreditation status to gain access to:
- BioVersys Current Valuation
- BioVersys Stock Price
- BioVersys Management
- Available deals in BioVersys and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- BioVersys Cap Table and Funding History by Share Class and Liquidity Preferences
- BioVersys Revenue and Financials
- BioVersys Highlights
- BioVersys Business Model
- BioVersys Risk Factors
- BioVersys Research Report from SACRA Research
Trading BioVersys Stock
How to invest in BioVersys stock?
Accredited investors can buy pre-IPO stock in companies like BioVersys through EquityZen funds. These investments are made available by existing BioVersys shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell BioVersys stock?
Shareholders can sell their BioVersys stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
